Cancer and transplant: A delicate balance

Abstract

“The AJT Report” reports on efforts in the transplant and oncology communities to expand access to transplantation for patients who have had cancer. We also share details on the recently launched Post‐Transplant Cancer Project.

Nephrological management of renal cell carcinoma (RCC) patients: A narrative review

“…Although transplant-specific data are limited, it is clear that patients who have had a previous cancer are at a higher risk for both recurrence, as well as a de novo malignancy. 82 All transplanted patients have an increased risk for cancer compared to the general population; thus, they should be educated about the risk and correctly directed to specialty consultations and oncological screenings.…”

“…In fact, it is complex to balance immunosuppressive therapy with the use of ICIs and, in almost 50% of cases, brings the rejection of the graft. 82 Transplanted patients do not require any special attention before or after CM administration for CECT.…”

“…Although transplant-specific data are limited, it is clear that patients who have had a previous cancer are at a higher risk for both recurrence, as well as a de novo malignancy. 82…”

“…In fact, it is complex to balance immunosuppressive therapy with the use of ICIs and, in almost 50% of cases, brings the rejection of the graft. 82…”